|
Originally published In Press as doi:10.1074/jbc.M102334200 on August 10, 2001
J. Biol. Chem., Vol. 276, Issue 43, 39695-39704, October 26, 2001
Calcium Entry through L-type Calcium Channels Causes
Mitochondrial Disruption and Chromaffin Cell Death*
María F.
Cano-Abad §,
Mercedes
Villarroya ¶,
Antonio G.
García **,
Nelson H.
Gabilan , and
Manuela G.
López §§
From the Instituto de Farmacología
Teófilo Hernando, Departamento de Farmacología, Facultad
de Medicina, Universidad Autónoma de Madrid, C/Arzobispo Morcillo
4, Madrid 28029, Spain, Servicio de Farmacología
Clínica, Hospital de la Princesa, C/Diego de León 62, Madrid 28006, Spain, ** Instituto Universitario de
Investigaciones Gerontológicas y Metabólicas, Hospital de
la Princesa, C/Diego de León 62, Madrid 28006, Spain, and
 Departamento de Bioquímica,
Universidad Federal de Santa Catarina,
Florianópolis 88049SC, Brasil
Received for publication, March 15, 2001, and in revised form, July 5, 2001
 |
ABSTRACT |
Sustained, mild K+
depolarization caused bovine chromaffin cell death through a
Ca2+-dependent mechanism. During
depolarization, Ca2+ entered preferentially through
L-channels to induce necrotic or apoptotic cell death, depending on
the duration of the cytosolic Ca2+ concentration
([Ca2+]c) signal, as proven by the following. (i)
The L-type Ca2+ channel activators Bay K 8644 and FPL64176,
more than doubled the cytotoxic effects of 30 mM
K+; (ii) the L-type Ca2+ channel blocker
nimodipine suppressed the cytotoxic effects of K+ alone or
K+ plus FPL64176; (iii) the potentiation by FPL64176 of the
K+-evoked [Ca2+]c elevation was
totally suppressed by nimodipine. Cell exposure to
K+ plus the L-type calcium channel agonist FPL64176 caused
an initial peak rise followed by a sustained elevation of the
[Ca2+]c that, in turn, increased
[Ca2+]m and caused mitochondrial membrane
depolarization. Cyclosporin A, a blocker of the mitochondrial
transition pore, and superoxide dismutase prevented the apoptotic cell
death induced by Ca2+ overload through L-channels. These
results suggest that Ca2+ entry through L-channels causes
both calcium overload and mitochondrial disruption that will lead to
the release of mediators responsible for the activation of the
apoptotic cascade and cell death. This predominant role of L-type
Ca2+ channels is not shared by other subtypes of high
threshold voltage-dependent neuronal Ca2+
channels (i.e. N, P/Q) expressed by bovine chromaffin cells.
 |
INTRODUCTION |
Alteration of calcium homeostasis is hypothesized to contribute to
neuronal death following ischemia-reperfusion (1-5) or neurodegenerative diseases like Alzheimer's disease (6-11). An overload of neuronal Ca2+ may activate a number of
pathological processes like disruption of the mitochondrial membrane
potential, free radical production, stimulation of catabolic enzymes,
and enhancement of excitatory amino acid release that will lead to cell
death (12). Considerable attention has been focused on the possibility
of Ca2+ entry through the
N-methyl-D-aspartate-glutamate receptor
gated channel as responsible for Ca2+ overload, but other
sources are also being considered, such as release from intracellular
stores or Ca2+ influx through high threshold
voltage-dependent calcium channels (VDCC)1 (4, 13-15).
In neurons, several subtypes of high threshold and low threshold VDCC
(L-, N-, P/Q-, R-, and T-type) have been described (16-18). These
channels have different voltage sensitivities, kinetic properties, and
pharmacological profiles (16-19). L-type VDCC have been localized predominantly in the soma and proximal dendrites of neurons throughout the brain (19-21) and are sensitive to dihydropyridine activators (e.g. Bay K 8644) and blockers (e.g. nimodipine).
At the moment, there are enough pieces of evidence that support the
participation of Ca2+ entry through L-channels during
ischemia, to cause cell death (13, 14, 21-24). However, the mechanism
by which cell death is orchestrated by such Ca2+ entry has
not been defined precisely. In this work, we attempt to clarify such a
mechanism using the bovine adrenal medullary chromaffin cell as a
model. This cell expresses the same set of Ca2+ channel
subtypes described in neurons (25). Bovine chromaffin cells in primary
cultures constitute a homogeneous cell population that expresses
various subtypes of Ca2+ channels at relative densities
similar to certain types of neurons (i.e. granular
cerebellar neurons (about 20% L-type, 30% N-type, and 50% P/Q-type)
(26)). In addition, R-type channels have been recently discovered in
chromaffin cells using the perforated configuration of the patch-clamp
technique (27). Hence, bovine chromaffin cells constitute an adequate
model to investigate the problem posed here (i.e. (i) to
know whether Ca2+ entry through these channels during
sustained depolarization produced apoptotic cell death; (ii) to define
why the L-channel pathway is more efficacious to activate this lethal
signal; and (iii) to determine which is the role of mitochondria in the
activation of cell death.
 |
EXPERIMENTAL PROCEDURES |
Materials and Solutions--
Dulbecco's modified Eagle's
medium and fetal calf serum were obtained from Life Technologies, Inc.;
nimodipine, FPL64176, Bay K 8644, and superoxide dismutase (SOD) were
from Sigma; -conotoxin GVIA was from Bachem Feinchemikalien
(Switzerland); and -conotoxin MVIIC and -agatoxin IVA were from
the Peptide Institute (Osaka, Japan). The assay kit for measuring the
activity of lactate dehydrogenase (LDH) and Cell Death Detection
Elisaplus Kit were purchased from Roche Molecular Biochemicals.
Fura-2/AM, rhodamine 123, Vybrant Apoptosis Kit, and Mitotracker Red
were purchased from Molecular Probes, Inc.
Concentrated solutions of drugs were prepared in water ( -conotoxin
GVIA, -conotoxin MVIIC, -agatoxin IVA, superoxide dismutase), dimethyl sulfoxide (nimodipine, FPL64176), or ethanol (Bay K 8644). Appropriate dilutions were then made in Krebs-Hepes solution containing 144 mM NaCl, 5.9 mM KCl, 1.2 mM
MgCl2, 2 mM CaCl2, 10 mM Hepes, 11 mM glucose, pH 7.3, titrated with
NaOH. Me2SO, at the final concentration used (less
than 0.1%), had no effect on any of the parameters tested.
Preparation and Culture of Bovine Chromaffin Cells--
Bovine
adrenal medullary chromaffin cells were isolated as previously
described (28) with some modifications (29). To reduce the number of
endothelial cells in the culture that could alter LDH measurements,
cells were preplated for 30 min, and proliferation inhibitors (cytosine
arabinoside, L-leucine methyl esther, and fluorodeoxyuridine) were used during the maintenance of the culture in
the Dulbecco's modified Eagle's medium. For cell death studies, cells
were plated at a density of 5 × 105 cells/well on
24-well Orange plates coated with 0.01 mg ml 1 of
poly-L-lysine, containing 1 ml of Dulbecco's modified
Eagle's medium supplemented with 5% fetal calf serum, 10 µM cytosine arabinoside, 10 µM
fluorodeoxyuridine, 10 µM leucine methyl esther, 50 IU
ml 1 penicillin, and 50 µg ml 1
streptomycin. Cultures were maintained for 2-3 days at 37 °C in a
water-saturated atmosphere with 5% CO2. After 24 h,
the medium was replaced by 1 ml of serum-free fresh medium and
subsequently changed every 2-3 days. Cells were normally used during
days 2-3, to avoid excessive growth of endothelial cells that could
interfere with LDH measurements.
LDH Assay--
Extracellular and intracellular LDH
activities were spectrophotometrically measured by following
tetrazolium reduction at an absorbance wavelength of 492 nm. Total LDH
activity was defined as the sum of intracellular plus extracellular LDH
activity. Released LDH was defined as the percentage of extracellular
compared with total LDH activity (30).
Nuclear Staining of DNA--
For microscopic nuclear DNA
analysis, bovine chromaffin cells cultured in 24-well plates (5 × 105/well) were stained with 5 µg/ml Hoechst dye 33342 in
Krebs-Hepes solution for 30 min at 37 °C (31). Stained
cells were washed twice with phosphate-buffered saline, removed from
the well by gentle shaking, and placed in a plastic tube for
centrifugation at 800 rpm for 10 min. Supernatants were removed, and
cells were resuspended in 50 µl of phosphate-buffered saline. A
sample of 15 µl of the stained cells was placed on a coverslip and
counted under the fluorescent microscope. Fluorescence microscopy was performed using a Nikon Elipse TE300 microscope, using the appropriate filter for an excitation wavelength of 355 nm and an emission wavelength of 465 nm. Nuclei with the apoptotic features were counted
as apoptotic cells of a total of 300 cells in at least three different
batches of cells. The percentage was calculated for each sample.
DNA Fragmentation Analysis--
For the quantitative
determination of cytoplasmic histone-associated DNA fragments, the Cell
Death Detection Elisaplus Kit was used (32). After induction of
cell death, every well was treated with the lysis buffer for 30 min.
Samples were spun down at 200 × g for 10 min. An
aliquot from the supernatant (20 µl) was transferred to the
streptavidin-coated microplate for analysis. 80 µl of the
immunoreagent mixture prepared with volume of
anti-DNA-peroxidase and volume of anti-histone-biotin with
volumes of incubation buffer were added to each well and
maintained for 2 h at room temperature with gentle shaking.
Thereafter, the solution was removed by aspiration, and the wells were
rinsed three times with 250 µl of incubation buffer. Then 100 µl of
the substrate solution was added to each well and incubated for 5 min
until the color developed. Measurements were made at 600 nm. Results were expressed as the absorbance of each sample and compared with basal levels.
Measurement of Cytosolic Ca2+ Concentrations,
[Ca2+]c--
For these experiments, cells
were plated on 1-cm diameter glass coverslips at a density of 5 × 104 cells/coverslip. Cells were loaded with Fura-2/AM (4 µM) for 45 min at 37 °C in Krebs-Hepes solution.
Loading with the fluorescent dye was terminated by washing the
coverslip containing the attached cells twice with Krebs-Hepes; then
the cells were kept at room temperature for 15 min before placing them
in the headstage of a Nikon Diaphot microscope to measure their fluorescence.
The fluorescence of Fura-2 in single cells was measured with the
photomultiplier-based system (33), which produces a spatially averaged
measurement of the [Ca2+]c. Fura-2 was excited
with light alternating between 360 and 390 nm, using a Nikon × 40 fluorite objective. Emitted light was transmitted through a 425-nm
dichroic mirror and 500-545-nm barrier filter before being detected by
the photomultiplier. [Ca2+]c was calculated from
the ratios of the light emitted when the dye was excited by the two
alternating excitation wavelengths (34).
Measurements of Mitochondrial Transmembrane Potential ( m)
by Fluorescence Confocal Imaging--
The fluorescence of rhodamine
123 was used to measure  m (35). Cells were incubated for 30 min
in the presence of 10 µM of the dye. Rhodamine 123 was
added to all of the solutions used during the experiment, in order to
avoid washout of the dye. Three to six cells were studied in each
experiment. Images were collected at 1 image/0.372 s. Cellular
fluorescence was imaged using a MRC 6000 confocal laser-scanning
microscope with excitation at 488 nm and emission at 510 nm and a × 60 oil immersion objective. Pixel intensity/cell was determined
using Bio-Rad software. Base-line fluorescence (Fo) was
measured as normalized fluorescence emitted during the experiment.
Increments in fluorescence indicate mitochondrial depolarization. All
experiments were performed at 22 ± 1 °C in bovine chromaffin
cells cultured for 2-3 days.
Mitotracker Red to Visualize Mitochondria--
Cells were placed
in coverslips at a density of 3 × 105 cells. Control
and treated cells (0.3 µM FPL64176, 30 mM
K+, 5 mM Ca2+) were loaded with the
cell-permeant mitochondrial dye, Mitotracker red 100 nM at
37 °C for 30 min. Once the Mitotracker probe accumulates in
mitochondria, it reacts with accessible thiol groups of peptides and
proteins and forms an aldehyde conjugate that is stable. Fluorescent images were taken under a confocal laser-scanning microscope with excitation at 570 nm and emission at 599 nm (36, 37).
Statistical Analysis--
Data were expressed as means ± S.E. Statistical significance of differences between means was
determined by an analysis of variance test. If significant differences
were found, an appropriate multiple comparison test (Fisher PLSD) was
done. In some cases, Student's t test was used (see
Figs. 1 and 3-6 legends). Differences were considered
significant at the level of p < 0.05.
 |
RESULTS |
Cell Death as a Function of Depolarization and
Ca2+ Entry through L-type Calcium Channels: Protection by
Nimodipine--
To facilitate ionic manipulations, all experiments
were performed in Krebs-Hepes solutions. For instance, in the
experiment shown in Fig. 1a,
cells were incubated in Krebs-Hepes solution containing increasing
concentrations of KCl (5.9-50 mM), with isosmotic
reduction of NaCl, for 24 h at 37 °C. At the end of this
incubation period, the medium was collected to measure LDH released
from dead cells (extracellular LDH; LDHe); the cells that remained attached to the well were then lysed, and their LDH
content was measured. The expression of LDHe as a
percentage of total LDH provides an indication of the fraction of cells
dying as a consequence of a given treatment, in this case
depolarization of increasing strengths. Incubation of the cells for
24 h with increasing [K+]e gave a gradual
release of LDHe; maximum cell damage was observed at 30 mM K+, which caused 25% cell loss; a further
increase to 50 mM K+ did not enhance cell
death. Hence, 30 mM [K+]e was chosen
to perform subsequent experiments.

View larger version (28K):
[in this window]
[in a new window]
|
Fig. 1.
Cell death induced by Ca2+ entry
through L-channels depends on [Ca2+]e: Nimodipine
provides total cytoprotection. a, cell death expressed
as a percentage of LDH released to the external medium in chromaffin
cells incubated for 24 h with increasing concentrations of
[K+]e in the presence of 2 mM
Ca2+. Basal release refers to cells treated with a control
Krebs-Hepes solution containing 5.9 mM K+ and 2 mM Ca2+. b, the
[Ca2+]e dependence of the cell damage induced by
depolarization of the cells with 30 mM K+
during 24 h. c, dose-response curves of different
L-type Ca2+ channel agonists in 30 mM
K+ and 2 mM Ca2+. d,
total cytoprotection afforded by 1 µM nimodipine in the
presence of 0.3 µM FPL64176/30 mM
K+ at increasing [Ca2+]e. The
combination of toxins (1 µM MVIIC, 1 µM
GVIA, and 1 µM Aga IVA) to block N/P/Q-type
Ca2+ channels in the presence of 0.3 µM of
FPL64176 and 30 mM K+ afforded a cytoprotectant
effect at low [Ca2+]e (0.2, 0.5, and 2 mM) but not at high [Ca2+]e (5, 10, and 20 mM). Data are the mean ± S.E. of 9-12 wells
from three different batches of cells. ***, p < 0.001;
*, p < 0.05 with respect to basal release (analysis of
variance test).
|
|
Cell damage was not only a function of the degree of VDCC opened upon
depolarization with high [K+]e but also of the
quantity of external Ca2+ offered to the cells
([Ca2+]e). In a second experiment (Fig.
1b), the effects of increasing [Ca2+]e
on cell death, at a fixed level of depolarization (30 mM
K+), were assayed. Cell death after a 24-h incubation was
close to basal at 0.2-0.5 mM [Ca2+]e
(13% LDHe release); at 2-10 mM
[Ca2+]e, cell death increased to around 25%, and
it declined to 20% at 20 mM [Ca2+]e;
this effect could be due to inactivation by excess Ca2+ of
VDCC (38-40).
To increase the cell damage caused by Ca2+ entry through
L-type VDCC, we used different L-type agonists like FPL64176, (+)Bay K
8644, and ( )Bay K 8644 (41) under mild depolarizing conditions (30 mM [K+]e) for 24 h. Fig.
1c shows the cytotoxic consequence of the incubation with
these agonists at concentrations that ranged from 0.3 to 10 µM. Maximum cytotoxic effects, for all drugs tested, were
observed at 0.3-1 µM; higher concentrations of the
agonists (3-10 µM) presented a decrease in
LDHe; this effect can be explained by their
Ca2+ antagonist action at high concentrations (41, 42). Out
of the three L-type agonists used, FPL64176 presented the highest cytotoxic effects. Therefore, the combination of 0.3 µM
FPL64176 in 30 mM [K+]e was used to
induce cell death via Ca2+ entry through L-type VDCC.
The cytotoxic effect of Ca2+ entry through L-channels
induced by FPL64176 was dependent on the [Ca2+]e.
In Fig. 1d, basal LDHe (24-h incubation in 5.9 mM K+) amounted to 8.4 ± 0.9%; 0.3 µM FPL64176 in the presence of 30 mM
K+ increased the basal LDHe at all
[Ca2+]e studied. For instance, at 0.2 mM [Ca2+]e, LDHe
increased from 12.3 ± 2.6% (Fig. 1b) to 25.9 ± 2.6% in the presence of FPL. Maximum cell death was achieved in the
presence of 5-10 mM [Ca2+]e
(41.5 ± 2.0 and 43.5 ± 1.8%, respectively). It is interesting that this sharp increase in cell death could be completely reversed by a 1 µM concentration of the L-type
Ca2+ channel blocker nimodipine (Fig. 1d);
LDHe after 24 h was in the range of 10-15%
(i.e. similar to that found in basal conditions (5.9 mM K+)). It is worth noting that nimodipine
counteracted both the LDHe increase evoked by 30 mM K+ in the absence (about 25%) and in the
presence of FPL64176 (about 50%), suggesting that the increase in cell
death was associated to increased Ca2+ entry mostly through
L-type Ca2+ channels.
[Ca2+]c Signals and Cell Damage Generated
by K+ at Low and High [Ca2+]e:
Effects of FPL64176--
Since cell damage caused by depolarization
was minimum at 0.2 mM [Ca2+]e and
maximum at 5 mM [Ca2+]e, we selected
these extreme [Ca2+]e values to analyze the time
course of the [Ca2+]c signals in Fura-2-loaded
single cells exposed to 30 mM K+. Cells
superfused with 0.2 mM [Ca2+]e gave
an average initial basal [Ca2+]c of 55 ± 4.8 nM. Exposure to 30 mM
K+, 0.2 mM Ca2+ caused an
initial mean peak of 198 ± 39 nM (n = 8) (Fig. 3a). Despite the sustained depolarization with
K+, the [Ca2+]c peak declined quickly
to basal levels and remained stable along the rest of the 30-min period
of recording. In 5 mM [Ca2+]e, the
resting [Ca2+]c was 61 ± 5.9 nM (n = 7); upon superfusion with 30 mM K+, 0.2 mM
Ca2+, an initial [Ca2+]c peak
of 560 ± 45 nM was reached (n = 7);
then the peak [Ca2+]c declined gradually and
reached a stable plateau of 242 ± 79 nM.
The transient nature of the [Ca2+]c signal was
probably due to voltage- and
[Ca2+]c-dependent inactivation of
Ca2+ channels upon sustained cell depolarization (38-40).
This transient response of [Ca2+]c might explain
the scarce cell damage observed in the experiments of Fig.
1b. Hence, we tried to delay the inactivation of
Ca2+ channels by using the L-type Ca2+ channel
activator FPL64176. In the presence of 0.3 µM FPL64176, 30 mM K+, 0.2 mM
Ca2+, the initial peak of
[Ca2+]c reached 432 ± 130 nM
(n = 4) and then declined to reach a stable
Ca2+ entry of 299 ± 8 nM. Thus, FPL64176
converted the [Ca2+]c signal obtained in 0.2 mM [Ca2+]e into a response similar to
that produced by 5 mM [Ca2+]e. When
FPL64176 was applied in the presence of high [Ca2+]e (5 mM), the
[Ca2+]c rose initially to a peak of 905 ± 120 nM (n = 9) and then declined to a
sustained plateau that was 1.4-fold higher (409 ± 91 nM) than in low [Ca2+]e (0.2 mM), along the rest of the 30-min depolarization period
(Fig. 2d).

View larger version (20K):
[in this window]
[in a new window]
|
Fig. 2.
FPL64176 increases by 2-fold the
[Ca2+]c induced by 30 mM
K+ at low (0.2 mM) and high (5 mM)
[Ca2+]e. Shown are original
traces of single cell [Ca2+]c measurements in
Fura-2-loaded cells. The cell being explored was continuously
superfused with Krebs-Hepes solution containing 0.2 mM
(a and c) or 5 mM (b and
d) [Ca2+]e. The potentiating effect of
FPL64176 (0.3 µM) on the [Ca2+]c
signals can be observed in c and d at 0.2 and 5 mM [Ca2+]e, respectively.
|
|
When measuring the total quantity of Ca2+ entering the
cells during the 30-min exposure period in low (0.2 mM) or
high (5 mM) [Ca2+]e in the presence
or absence of FPL64176, we observed that the maximum levels of
[Ca2+]c were achieved when using 5 mM
[Ca2+]e plus FPL64176 (496 ± 77 nM·s) (n = 8). Ca2+ entry at
0.2 mM [Ca2+]e plus FPL64176 and 5 mM [Ca2+]e alone were rather similar,
317 ± 8 nM·s (n = 4) and 302 ± 62 nM·s (n = 8), respectively. The
same pattern was also observed when measuring the initial peak of
[Ca2+]c (see Fig.
3a).

View larger version (23K):
[in this window]
[in a new window]
|
Fig. 3.
Cell death as a function of
[Ca2+]c. a, the
average Ca2+ entry into the cell during a 30-min period, in
terms of area under the curve of [Ca2+]c
(nM·s) and maximum peak (nM) reached with a
mild depolarization with 30 mM [K+]e
in low (0.2 mM) or high (5 mM)
[Ca2+]e and in the presence or absence of the
L-type Ca2+ channel activator, FPL64176 (0.3 µM). Total Ca2+ entry ranged from 200 nM·s at low (0.2 mM)
[Ca2+]e without FPL64176 to 500 nM·s at high (5 mM)
[Ca2+]e in the presence of FPL64176. *,
p < 0.05; **, p < 0.01 with respect
to 0.2 mM Ca2+ or 5 mM
Ca2+ in the absence of FPL64176 (Student's t
test). b shows the correlation between total
Ca2+ entry (nM·s) and cell death expressed as
LDHe release (% total). Maximum cell death was
reached at 5 mM [Ca2+]e, 30 mM K+, and 0.3 µM FPL64176. Data
are the mean ± S.E. of 8-10 cells from three different batches
of cells.
|
|
When analyzing cell lesions as LDHe released, we observed
that the amount of Ca2+ entering the cell during 30 min,
measured as the integral of the curve of [Ca2+]c,
correlated well with the extent of cell death observed 24 h later
(see Fig. 3b). These results prove that cell lesion is a
function of the quantity of Ca2+ entering through VDCC and
that it depends not only on the [Ca2+]e but also
on the inactivation state of those channels.
Cytoprotection Afforded by Nimodipine Is Related to the Reduction
of [Ca2+]c--
We had previously observed
(Fig. 1d) that 1 µM nimodipine completely
counteracted LDH release induced by Ca2+ overload through
L-type Ca2+ channels. In order to determine if the
protection afforded by nimodipine was related to a reduction in the
levels of [Ca2+]c, we performed experiments in
single Fura-2/AM-loaded cells. Fig. 4
shows how nimodipine restored the [Ca2+]c to
basal levels after the [Ca2+]c was raised by
FPL64176, 30 mM K+, both at low (0.2 mM), (Fig. 4a) and high (5 mM) (Fig.
4b) [Ca2+]e. Total Ca2+
entry, analyzed as the area under the curve, in the presence and
absence of nimodipine was significantly reduced from 80 ± 8 µM·s to 10 ± 1 µM·s
(n = 5) at 0.2 mM
[Ca2+]e and from 120 ± 12 µM·s to 15 ± 1 µM·s
(n = 5) at 5 mM
[Ca2+]e (Fig. 4c). This drastic
reduction in the [Ca2+]c could explain the total
cytoprotection observed previously with nimodipine (see Fig.
1d).

View larger version (17K):
[in this window]
[in a new window]
|
Fig. 4.
Nimodipine returned to basal levels the
[Ca2+]c rise induced by FPL64176. In single
Fura-2-loaded cells stimulated with 0.3 µM FPL64176, 30 mM K+, nimodipine (1 µM) reduced
the [Ca2+]c to basal levels (a); this
effect was reversible (b). c represents total
mean Ca2+ entry obtained during 5 min with 0.3 µM FPL64176/30 mM K+ at low (0.2 mM) or high (5 mM)
[Ca2+]e, alone or in the presence of nimodipine.
***, p < 0.001 with respect to the depolarizing pulse
in the absence of nimodipine (Student's t test).
|
|
Since nimodipine is selectively blocking L-type Ca2+
channels, it seemed obvious that N- and P/Q-type Ca2+
channels would not be contributing to the Ca2+ signals or
to the LDHe release in cells exposed to Ca2+
overload through L-channels. This possibility was verified by measuring
both [Ca2+]c changes and cell death in the
presence of non-L-type Ca2+ channel blockers ( -conotoxin
GVIA for N-channels plus -conotoxin MVIIC for N/P/Q-channels). When
measuring cell damage as a function of LDH release in depolarized cells
treated with FPL64176 at different [Ca2+]e
(0.2-20 mM), we curiously observed significant
cytoprotection by N/P/Q-type blockers at low
[Ca2+]e (0.2-2 mM) but not at higher
concentrations (i.e. above 5 mM; see Fig.
1d). However, the increase of [Ca2+]c
induced by FPL64176, 30 mM K+ in low and high
[Ca2+]e was not significantly modified in the
presence of the non-L-type channel blockers (data not shown).
Prolonged Ca2+ Entry through L-type Channels Leads
Primarily to Necrotic Cell Death--
To further understand the basic
mechanism by which chromaffin cells were dying upon their sustained
depolarization, we compared the amount of necrosis measured as LDH
release and apoptosis measured as histone-associated DNA fragments in
cells exposed for 24 h to FPL64176, 30 mM
K+, 5 mM Ca2+. Fig.
5a shows that the cytotoxic
effect of Ca2+ entry through L-channels induced significant
LDHe release but no significant increase in the number of
apoptotic cells. These results suggest that the elevation of
[Ca2+]c during prolonged depolarizations, in the
presence of an L-type channel activator, constitutes predominantly a
necrotic signal.

View larger version (41K):
[in this window]
[in a new window]
|
Fig. 5.
Sustained Ca2+ overload through
L-channels mediates necrotic cell death. a, cell death
measured as apoptosis (black columns) or necrosis
(white columns), at low (0.2 mM) or
high (5 mM) [Ca2+]e in the presence
of the depolarizing mixture (0.3 µM FPL64176/30
mM K+) for 24 h. Data correspond to the
mean + S.E. of four experiments from three different batches of cells.
Statistical differences were observed among the LDHe measurements but
not for the apoptotic measurements. **, p < 0.01 with
respect to basal level (Student's t test). Shown are
mitochondria stained with the fluorescent dye Mitotracker red, in a
resting cell (b) and in a cell exposed to calcium overload
through L-channels (0.3 µM FPL64176, 30 mM
K+, 5 mM Ca2+)
(c).
|
|
During cell necrosis, dramatic changes can be observed in the
mitochondrial structure (9). The morphological changes in the
mitochondria network induced by prolonged (24-h) Ca2+ entry
through L-channels could be observed in cells stained with the
mitochondrial dye Mitotracker red. Chronic treatment with FPL64176
induced total disruption of the mitochondrial mesh (Fig. 5c), indicating cell necrosis. In contrast, the control cell
in Fig. 5b presents the mitochondrial network completely preserved.
Transient Ca2+ Overload through L-channels Mediates
Apoptotic Cell Death Secondary to the Release of Cytochrome c and
Free Radicals from the Mitochondria--
During an ischemic episode, a
transient lack of oxygen normally occurs. Therefore, we tried
experimental conditions where Ca2+ overload through
L-channels (0.3 µM FPL64176, 30 mM
K+, 5 mM Ca2+) had a duration of 30 min; we evaluated the cytotoxic consequence of such stimulus, measuring
cell death as release of LDH (immediately after the stimulus) and the
number of apoptotic nuclei (48 h after the stimulus) with the
fluorescent dye Hoechst. We found that Ca2+ entering
through L-channels for 30 min almost doubled the basal release of LDH
and increased the number of apoptotic nuclei from 11 ± 0.7%
(basal) to 26.8 ± 3.3% (depolarizing pulse) after 48 h
(Fig. 6a). These results
contrast with those obtained when the toxic stimulus (0.3 µM FPL64176, 30 mM K+, 5 mM Ca2+) was kept for 24 h (Fig. 5). In
the latter case, no significant increase in the number of apoptotic
nuclei was observed; the main lesion found was necrotic. These results
indicated that shorter increases in the [Ca2+]c
were capable of activating the apoptotic cascade; the question now was
to verify how this mechanism was taking place.

View larger version (32K):
[in this window]
[in a new window]
|
Fig. 6.
Transient Ca2+ entry through
L-channels mediates necrotic and apoptotic cell death. A
depolarizing period of 30 min (0.3 µM FPL64176, 30 mM K+, 5 mM Ca2+)
induced significant increase in the percentage of apoptotic nuclei
measured with the fluorescent dye Hoechst 48 h later
(a) and necrotic cell death measured as percentage of
LDHe immediately after the cytotoxic pulse (b).
SOD (1500 units), nimodipine (1 µM), and CsA (3 µM), during the 30-min depolarization period, prevented
the delayed apoptotic cell death (a). Early necrotic cell
death, measured as LDHe, was prevented by nimodipine and
SOD but not by CsA (b). Data correspond to the mean ± S.E. of three experiments from three different batches of cells. *,
p < 0.05; ***, p < 0.001 with respect
to 0.3 µM FPL64176, 30 mM K+
(Student's t test).
|
|
Transient peaks in [Ca2+]c can secondarily
increase mitochondrial Ca2+
([Ca2+]m), lead to the opening of the
mitochondrial transition pore (43), release of cytochrome
c (36) with the resultant release of oxygen free radicals
(like superoxide) from the electron transport chain (44, 45), and
initiate the apoptotic cascade (46). To determine if the cells were
dying through this mechanism, we performed two types of experiments:
(i) blockade of the opening of the transition pore by CsA (3 µM) and the subsequent release of cytochrome c
and (ii) use of the antioxidant enzyme SOD to prevent the action of
superoxide free radicals that could be released from mitochondria. When
CsA and SOD were present during the 30-min depolarizing pulse (0.3 µM FPL64176, 30 mM K+, 5 mM Ca2+), the number of apoptotic nuclei
returned to basal levels (10.8 ± 2.3 and 7.5 ± 2.4%,
respectively), indicating that release of cytochrome c and
free radicals was involved in inducing apoptosis via Ca2+
entry through L-channels. When Ca2+ entry was prevented
with nimodipine (1 µM), apoptotic cell death was also
prevented (Fig. 6a).
Cell death measured as LDH released in the first 30 min was
completely counteracted when SOD and nimodipine were present during the
30-min depolarizing pulse, but not by CsA (Fig. 6b).
These results suggest that the amount of Ca2+ entering the
cell with FPL64176, 30 mM K, 5 mM
Ca2+ during 30 min, that corresponds to 496 ± 77 nM·s of [Ca2+]c, mediates early
necrotic cell death (LDHe) and late apoptosis. Early
necrotic cell death and late apoptosis could be prevented by nimodipine
and SOD. Therefore, blockade of L-channels and superoxide radicals are
involved both in early necrotic and late apoptotic cell death. The fact
that CsA did not protect against early necrosis suggests that release
of cytochrome c, under these experimental conditions, is
primarily activating the apoptotic cascade and cell death at later stages.
Calcium Overload through L-type Ca2+ Channels Increases
Mitochondrial [Ca2+], Mitochondrial Membrane
Depolarization, and Release of Free Radicals--
Mitochondria are
involved in Ca2+ sequestration during an excytotoxic insult
(47). Recent studies have begun to clarify the deleterious effects that
may result from mitochondrial Ca2+ overload. Rapid
Ca2+ uptake causes mitochondrial depolarization (48),
impairment of energy metabolism (49), and uncoupling of electron
transport from ATP production (50, 51) and cell death.
With this background in mind, we carried out experiments to determine
whether Ca2+ driven through L-type Ca2+
channels was being seen primarily by the mitochondria and if this
Ca2+ was able to depolarize the mitochondrial membrane
that, in turn, would lead to cell death. Fluorescence measurements of
[Ca2+]c were performed in single loaded cells
with Fura-2/AM. Fig. 7a shows
an original trace of an experiment where two initial control (0.3 µM FPL64176, 30 mM K+, 5 mM Ca2+) depolarizing pulses (10 s) were
applied, followed by a pulse in the presence of the protonophore CCCP
(2 µM) or after pretreatment with CCCP for 20 s. In
both cases, when Ca2+ uptake by mitochondria was prevented
with CCCP, the [Ca2+]c signal almost doubled that
of control pulses.

View larger version (17K):
[in this window]
[in a new window]
|
Fig. 7.
Mitochondria are buffering Ca2+
overload through L-channels. In a and b,
cells were loaded with the fluorescent dye Fura-2/AM to monitor the
[Ca2+]c. a shows two control
depolarizations with 0.3 µM FPL64176, 30 mM
K+, 5 mM Ca2+ for 10 s. In the
presence of the protonophore CCCP (2 µM),
Ca2+ overload through L-channels increased
[Ca2+]c 2-fold with respect to the control
pulses. Pretreatment of the cell with CCCP for 10 s and CCCP plus
the depolarizing pulse in the following 10-s pulse increased
[Ca2+]c substantially, indicating the
participation of mitochondria in [Ca2+]c
buffering. The same protocol was followed in b, to test the
calcium buffering capacity of the endoplasmic reticulum; the cell was
superfused with caffeine (10 mM), ryanodine (10 µM), and thapsigargin (1 µM) for 3 min,
previous to the depolarizing pulse, to deplete the endoplasmic
reticulum Ca2+. Under these conditions, the
[Ca2+]c was not modified.
|
|
A similar experimental procedure was carried out to test the
contribution of the endoplasmic reticulum to the buffering of Ca2+ entering through L-type Ca2+ channels
(Fig. 7b). After the application of two control pulses (0.3 µM FPL64176, 30 mM K+, 5 mM Ca2+), the endoplasmic reticulum was
depleted using the combination of 10 mM caffeine, 10 µM ryanodine, and 1 µM thapsigargin. The depolarizing pulse given in the presence of the endoplasmic
reticulum-depleting solution did not increase the intracellular
Ca2+ signal, indicating little or no contribution of the
endoplasmic reticulum to the buffering of cytosolic Ca2+ in
these experimental conditions. Therefore, these results suggest that
mitochondria are the main buffering system for Ca2+
overload through L-channels.
In order to determine whether [Ca2+]c elevations
mediated by activation of L-channels (FPL64176, 30 mM
K+, 5 mM Ca2+) were able to
depolarize the mitochondria, we measured the  m with the
fluorescent dye rhodamine 123. Confocal images were taken every 0.372 s. Fig. 8 shows experiments that
illustrate how FPL64176, 30 mM K+, 5 mM Ca2+ induced increases in the fluorescence
of rhodamine 123, indicating mitochondrial membrane depolarization;
when the same cell was perfused with FPL, 30 mM
K+, 5 mM Ca2+ in the presence of
nimodipine, mitochondrial depolarization was prevented. These results
demonstrate that depolarization of the mitochondrial membrane occurs
when an elevation of [Ca2+]c occurs, in this case
after the opening of L-type Ca2+ channels.

View larger version (44K):
[in this window]
[in a new window]
|
Fig. 8.
Ca2+ entry through L-channels
depolarizes the mitochondrial membrane, an effect that could be
prevented by nimodipine. After recording base-line fluorescence of
rhodamine 123, the cells were exposed for 10 s to 0.3 µM FPL64176, 30 mM K+, 5 mM Ca2+; a direct depolarization of the
mitochondria could be seen as an increase of fluorescence. After
washout, the same cell was again stimulated with FPL64176, 30 mM K+, 5 mM Ca2+ in the
presence of 1 µM nimodipine (added 2 min before), and the
increase in fluorescence was completely abolished. The same set of
stimuli were repeated in the same cell. b and c
represent the sequential fluorescent images obtained in a confocal
microscope of the first and second stimuli presented in
a.
|
|
 |
DISCUSSION |
We demonstrate in this study that sustained, mild K+
depolarization causes chromaffin cell death (Fig. 1b)
through a Ca2+-dependent mechanism. Under these
conditions, Ca2+ can gain the cell cytosol through several
of the voltage-dependent Ca2+ channels
described in bovine chromaffin cells. As indicated by numerous
patch-clamp studies, external Ca2+ enters the
voltage-clamped bovine chromaffin cell during depolarization through
L-type (20%), N-type (30%), and P/Q-type (50%) Ca2+
channels (see Ref. 18). Despite this, it was curious that most of the
Ca2+ entering through L-channels, but not through N- or
P/Q-channels, was responsible for the activation of the death signal,
as proven by the following observations. (i) The L-type
Ca2+ channel activators Bay K 8644 and FPL64176 more than
doubled the cytotoxic effects of 30 mM K+; (ii)
the L-type Ca2+ channel blocker nimodipine suppressed the
cytotoxic effects of 30 mM K+ alone or 30 mM K+ plus FPL64176; (iii) conversely, toxin
blockade of N- and P/Q-channels caused partial cytoprotection at 0.2-2
mM [Ca2+]e and no protection at 5-20
mM [Ca2+]e; and (iv) the potentiation
by FPL64176 of the K+-evoked [Ca2+]c
elevation was suppressed by nimodipine.
The partial cytoprotection afforded by combined toxins at the lower
[Ca2+]e is puzzling but can surely be interpreted
in the context of the recent finding of our laboratory showing the
Ca2+-dependent inactivation of L-, N-, and
P/Q-channels in voltage-clamped bovine chromaffin cells (39). The
elevation of [Ca2+]c elicited by the
mitochondrial uncoupler CCCP during cell depolarization causes a faster
inhibition of N- and P/Q-channels, as compared with L-channels. This
might explain why, in the present study, Ca2+ entry through
L-type Ca2+ channels caused greater cell lesion than that
gained through N- and P/Q-channels. Despite the fact that L-channels
account for only one-fifth of the total Ca2+ entering the
cell during depolarization, they are capable of triggering a cell death
signal with more efficacy than N- or P/Q-channels. Now the question
arises as to how such Ca2+ entry through L-channels causes
cell death.
Prolonged depolarization induced by K+ caused a transient
sharp rise of [Ca2+]c followed by a sustained
plateau. Although this bulk [Ca2+]c elevation
reached only around 1 µM, it is certain that mitochondria
see greater Ca2+ transients at subplasmalemmal sites near
the Ca2+ channels; thus, using mitochondrially targeted
aequorin, we have recently shown that Ca2+ inside the
mitochondria can reach near millimolar concentrations during cell
depolarization (52). If these elevations of
[Ca2+]m are sustained, then the mitochondrial
transition pore will open (49, 53, 54), and the apoptotic cascade will
be activated. These findings suggest the following. (i) Cell exposure to K+ plus FPL64176 caused depolarization of mitochondria,
surely due to mitochondrial Ca2+ accumulation; (ii) CsA, a
blocker of the mitochondrial transition pore, prevented the apoptotic
cell death induced by K+ plus FPL64176; (iii) and SOD also
suppressed this apoptotic signal, suggesting that mitochondrial
Ca2+ overload was generating free radicals to cause cell
death (13, 55, 56).
It is interesting that nimodipine provided full protection against both
necrotic and apoptotic cell death. This finding reinforces the view
that nimodipine might have direct neuroprotectant effects on neurons
subjected to an ischemic insult (14, 57) in addition to its well known
cerebrovascular vasodilatory effects (58). The neuroprotectant actions
of nimodipine in clinical trials performed in patients suffering a
thrombotic stroke have proven difficult to demonstrate (59-61).
However, in experimental animal models of cerebral ischemia, a clear
nimodipine-induced neuroprotection has been shown (22, 62), which is in
line with the results of the experiments shown here.
In conclusion, our data suggest that N- and P/Q-type Ca2+
channels, which suffer rapid Ca2+-dependent
inhibition after cell depolarization, are unlikely to contribute to
cell death upon a depolarizing stimulus. This observation is in line
with previous data from our laboratory indicating that blockers of N-
and P/Q-type Ca2+ channels did not protect against
veratridine-induced cell death (64, 65). However, they disagree with
the observation that N-type Ca2+ channel blockers afforded
protection in a rat model of cerebral ischemia (15). In contrast,
L-type channels that are localized preferentially at the neuronal soma
(66) inactivate more slowly and are clearly associated with cell
Ca2+ overload, mitochondria depolarization, generation of
free radicals, and cell death. These data strengthen the view that
Ca2+ entry through L-channels during a cerebral ischemic
condition causing neuronal depolarization (67) might be a critical
determinant of delayed death of neurons located in the penumbra area.
Hence, dihydropyridine blockers of L-channels should have pronounced neuroprotectant actions if given with an adequate therapeutic window to
stroke patients.
 |
ACKNOWLEDGEMENT |
We thank A. Garcia for computer assistance.
 |
FOOTNOTES |
*
This work was supported in part by Dirección General
de Investigación Científica y Técnica DGICYT Grants
PM99-004 (to A. G. G.) and PM99-0006 (to M. G. L.) and "CAM
Grupos Estratégicos del III PRICIT" (to A. G. G.).The costs of publication of this article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
§
Postdoctoral fellow of Fundación Teófilo Hernando.
¶
Postdoctoral fellow of Comunidad Autónoma of Madrid, Spain.
§§
To whom correspondence should be addressed: Dept. de
Farmacología, Facultad de Medicina, Universidad Autónoma
de Madrid, C/Arzobispo Morcillo 4, Madrid 28029, Spain. Tel.:
34-91-3975386; Fax: 34-91-3975397; E-mail:
manuela.garcia@uam.es.
Published, JBC Papers in Press, August 10, 2001, DOI 10.1074/jbc.M102334200
 |
ABBREVIATIONS |
The abbreviations used are:
VDCC, voltage-dependent calcium channels;
SOD, superoxide
dismutase;
LDH, lactate dehydrogenase;
[Ca2+]c, cytosolic Ca2+ concentration;
[Ca2+]m, mitochondrial Ca2+
concentration;
 m, mitochondrial transmembrane potential;
LDHe, extracellular LDH;
[K+]e and [Ca2+]e, external
K+ and Ca2+ concentration, respectively.
 |
REFERENCES |
| 1.
|
Cheung, J. Y.,
Bonventre, J. V.,
Malis, C. D.,
and Leaf, A.
(1986)
N. Engl. J. Med.
314,
1670-1676[Medline]
[Order article via Infotrieve]
|
| 2.
|
Choi, D. W.
(1995)
Trends Neurosci.
18,
58-60[CrossRef][Medline]
[Order article via Infotrieve]
|
| 3.
|
Siesjö, B. K.
(1981)
Cereb. Blood Flow Metab.
1,
155-185[Medline]
[Order article via Infotrieve]
|
| 4.
|
Small, D. L.,
Monette, R.,
Buchan, A. M.,
and Morley, P.
(1997)
Brain Res.
753,
209-218[CrossRef][Medline]
[Order article via Infotrieve]
|
| 5.
|
Fern, R.,
Davis, P.,
Waxman, S. G.,
and Ransom, B. R.
(1998)
J. Neurophysiol.
79,
95-105[Abstract/Free Full Text]
|
| 6.
|
Ueda, K.,
Shinohara, S.,
Yagami, T.,
Asakura, K.,
and Kawasaki, K.
(1997)
J. Neurochem.
68,
265-271[Medline]
[Order article via Infotrieve]
|
| 7.
|
Mattson, M. P.,
Cheng, B.,
Davis, D.,
Bryant, K.,
Lieberburg, I.,
and Rydel, R. E.
(1992)
J. Neurochem.
12,
376-389
|
| 8.
|
Mattson, M. P.,
Barger, S. W.,
Cheng, B.,
Lieberburg, I.,
Smith-Swintosky, V. L.,
and Rydel, R. E.
(1993a)
Brain Res.
16,
409-415
|
| 9.
|
Mattson, M. P.,
Tomaselli, K. J.,
and Rydel, R. E.
(1993)
Brain Res.
621,
35-49[CrossRef][Medline]
[Order article via Infotrieve]
|
| 10.
|
Goodman, Y.,
and Mattson, M. P.
(1994)
Exp. Neurol.
128,
1-12[CrossRef][Medline]
[Order article via Infotrieve]
|
| 11.
|
Goodman, Y.,
Steiner, M. R.,
Steiner, S. M.,
and Mattson, M. P.
(1994b)
Brain Res.
654,
171-176[CrossRef][Medline]
[Order article via Infotrieve]
|
| 12.
|
Keyser, D. J.,
Sulter, G.,
Langedijk, M.,
Elting, J. W.,
and Van der Naalt, J.
(1999)
Acta Clin. Belg.
54,
302-305[Medline]
[Order article via Infotrieve]
|
| 13.
|
Mason, R. P.,
Leeds, P. R.,
Jacob, R. F.,
Hough, C. J.,
Zhang, K. G.,
Mason, P. E.,
and Chuang, D. M.
(1999)
J. Neurochem.
72,
1448-1456[CrossRef][Medline]
[Order article via Infotrieve]
|
| 14.
|
Pisani, A.,
Calabresi, P.,
Tozzi, A.,
D'Angelo, V.,
and Bernardi, G.
(1998)
Stroke
29,
196-202[Abstract/Free Full Text]
|
| 15.
|
Valentino, K.,
Newcomb, R.,
Gadbois, T.,
Singh, T.,
Bowersonx, S.,
Bitner, S.,
Justice, A.,
Yamashiro, D.,
Hoffman, B. B.,
Ciaranello, R.,
Miljanich, G.,
and Ramachandran, J.
(1993)
Proc. Natl. Acad. Sci. U. S. A.
90,
7894-7897[Abstract/Free Full Text]
|
| 16.
|
Takahashi, T.,
and Momiyama, A.
(1993)
Nature
366,
156-158[CrossRef][Medline]
[Order article via Infotrieve]
|
| 17.
|
Olivera, B. M.,
Miljanich, G.,
Ramachandran, J.,
and Adams, M. E.
(1994)
Annu. Rev. Biochem.
63,
823-867[CrossRef][Medline]
[Order article via Infotrieve]
|
| 18.
|
García, A. G.,
Gandía, L.,
López, M. G.,
and Montiel, C.
(2000)
in
Seafood and Freshwater Toxins: Pharmacology, Physiology, and Detection
(Luis, M., ed)
, pp. 99-124, Botana, New York
|
| 19.
|
Hell, J. W.,
Westenbroek, R. E.,
Warner, C.,
Ahlijanian, M. K.,
Prystay, W.,
Gilbert, M. M.,
Snutch, T. H.,
and Catteral, W. A.
(1993)
J. Cell Biol.
123,
949-962[Abstract/Free Full Text]
|
| 20.
|
Ahlijanian, M. K.,
Westenbroek, R. E.,
and Catterall, W. A.
(1990)
Neuron
4,
819-832[CrossRef][Medline]
[Order article via Infotrieve]
|
| 21.
|
Westebroek, R. E.,
Ahlijanian, M. K.,
and Catterall, W. A.
(1990)
Nature
347,
281-284[CrossRef][Medline]
[Order article via Infotrieve]
|
| 22.
|
Kobayashi, T.,
and Mori, Y.
(1998)
Eur. J. Pharmacol.
363,
1-15[CrossRef][Medline]
[Order article via Infotrieve]
|
| 23.
|
Koh, J. Y.,
and Cotman, C. W.
(1992)
Brain Res.
587,
233-240[CrossRef][Medline]
[Order article via Infotrieve]
|
| 24.
|
Leski, H. L.,
Stacey, L. V.,
and Coyle, J. T.
(1999)
Brain Res.
828,
27-40[CrossRef][Medline]
[Order article via Infotrieve]
|
| 25.
|
Albillos, A.,
García, A. G.,
Olivera, B. M.,
and Gandía, L.
(1996)
Pflügers Arch. Eur. J. Physiol.
432,
1030-1038[CrossRef][Medline]
[Order article via Infotrieve]
|
| 26.
|
Tsien, R. W.,
Ellinor, P. T.,
and Horne, W. A.
(1991)
Trends Pharmacol. Sci.
12,
349-354[CrossRef][Medline]
[Order article via Infotrieve]
|
| 27.
|
Albillos, A.,
Neher, E.,
and Moser, T.
(2000)
J. Neurosci.
20,
8323-8330[Abstract/Free Full Text]
|
| 28.
|
Livett, B. G.
(1984)
Physiol. Rev.
64,
1103-1161[Free Full Text]
|
| 29.
|
Moro, M. A.,
López, M. G.,
Gandía, L.,
Michelena, P.,
and García, A. G.
(1990)
Anal. Biochem.
185,
243-248[CrossRef][Medline]
[Order article via Infotrieve]
|
| 30.
|
Cano-Abad, M. F.,
López, M. G.,
Hernández-Guijo, J. M.,
Zapater, P.,
Gandía, L.,
Sánchez-García, P.,
and García, A. G.
(1998)
Br. J. Pharmacol.
124,
1187-1196[CrossRef][Medline]
[Order article via Infotrieve]
|
| 31.
|
Mark, R. J.,
Henesley, K.,
Butterfield, D. A.,
and Mattson, M. P.
(1995)
J. Neurosci.
15,
6239-6249[Abstract]
|
| 32.
|
Kapila, Y. L.,
Wang, S.,
and Johnson, P. W.
(1999)
J. Biol. Chem.
274,
30906-30913[Abstract/Free Full Text]
|
| 33.
|
Neher, E.
(1989)
in
Neuromuscular Junction
(Sellin, L. P.
, Libelius, R.
, and Thesleff, S., eds)
, pp. 65-76, Elsevier, Amsterdam
|
| 34.
|
Grynkiewicz, G.,
Poenie, M.,
and Tsien, R. Y.
(1985)
J. Biol. Chem.
260,
3440-3450[Abstract/Free Full Text]
|
| 35.
|
Mattson, M. P.,
Zhang, Y.,
and Bose, S.
(1993c)
Exp. Neurol.
121,
1-13[CrossRef][Medline]
[Order article via Infotrieve]
|
| 36.
|
Krajeweski, S.,
Krajeweski, M.,
Ellerby, L. M.,
Welsh, K.,
Xie, Z.,
Deverausx, Q. L.,
Salvensen, G. S.,
Bredesen, D. E.,
Rosenthal, R. E.,
Fiskum, G.,
and Reed, J. C.
(1999)
Proc. Natl. Acad. Sci. U. S. A.
96,
5752-5757[Abstract/Free Full Text]
|
| 37.
|
Grouselle, M.,
Tueux, O.,
Dabadie, P.,
Georgescand, D.,
and Mazat, J. P.
(1990)
Biochem. J.
271,
269-272[Medline]
[Order article via Infotrieve]
|
| 38.
|
Villarroya, M.,
Olivares, R.,
Ruiz, A.,
Cano-Abad, M.,
De Pascual, R.,
Lomax, R. B.,
López, M. G.,
and García, A. G.
(1999)
J. Physiol.
516,
421-432[Abstract/Free Full Text]
|
| 39.
|
Henández-Guijo, J. M.,
Maneu-Flores, V. E.,
Ruiz-Nuño, A.,
Villarroya, M.,
García, A. G.,
and Gandía, L.
(2001)
J. Neurosci.
21,
2553-2560[Abstract/Free Full Text]
|
| 40.
|
Michelena, P.,
García-Pérez, L. E.,
Artalejo, A. R.,
and García, A. G.
(1993)
Proc. Natl. Acad. Sci. U. S. A.
90,
3284-3288[Abstract/Free Full Text]
|
| 41.
|
García, A. G.,
Sala, F.,
Reig, J. A.,
Viniegra, S.,
Frias, J.,
Fonteríz, R.,
and Gandía, L.
(1984)
Nature
309,
69-71[CrossRef][Medline]
[Order article via Infotrieve]
|
| 42.
|
Fonteríz, R. I.,
Gandía, L.,
López, M. G.,
Artalejo, C. R.,
and García, A. G.
(1987)
Brain Res.
408,
359-363[CrossRef][Medline]
[Order article via Infotrieve]
|
| 43.
|
Kruman, I. I.,
and Mattson, M. P.
(1999)
J. Neurochem.
72,
529-540[CrossRef][Medline]
[Order article via Infotrieve]
|
| 44.
|
Turrens, J. F.,
Alexander, A.,
and Lehninger, A. L.
(1985)
Arch. Biochem. Biophys.
237,
408-414[CrossRef][Medline]
[Order article via Infotrieve]
|
| 45.
|
Coyle, J. P.,
and Puttfarcken, P.
(1993)
Science
262,
689-696[Abstract/Free Full Text]
|
| 46.
|
Szalai, G.,
Krishnamurthy, R.,
and Hajnoczky, G.
(1999)
EMBO J.
22,
6349-6361[CrossRef]
|
| 47.
|
Griffiths, E. J.,
and Halestrap, A. P.
(1995)
Biochem. J.
307,
93-98
|
| 48.
|
Schinder, A. F.,
Olsen, E. C.,
Spitzer, N. C.,
and Montal, M.
(1996)
J. Neurosci.
16,
6125-6133[Abstract/Free Full Text]
|
| 49.
|
Duchen, M. R.
(1999)
J. Physiol.
516,
1-17[Abstract/Free Full Text]
|
| 50.
|
Beatrice, M. C.,
Palmer, J. N.,
and Pfeiffer, D. R.
(1980)
J. Biol. Chem.
255,
86663-8671
|
| 51.
|
Gunter, T. E.,
and Pleiffer, D. R.
(1990)
Am. J. Physiol.
258,
C755-C786[Abstract/Free Full Text]
|
| 52.
|
Montero, M.,
Alonso, M. T.,
Carnicero, E.,
Cuchillo, I.,
Albillos, A.,
García, A. G.,
García-Sancho, J.,
and Alvarez, J.
(2000)
Nat. Cell Biol.
2,
57-61[CrossRef][Medline]
[Order article via Infotrieve]
|
| 53.
|
Green, D. R.,
and Reed, J. C.
(1998)
Nature
281,
1309-1312
|
| 54.
|
Hengartner, M. O.
(2000)
Nature
407,
770-776[CrossRef][Medline]
[Order article via Infotrieve]
|
| 55.
|
Carriedo, S. G.,
Yin, H. Z.,
Sensi, S. L.,
and Weiss, J. H.
(1998)
J. Neurosci.
18,
7727-7738[Abstract/Free Full Text]
|
| 56.
|
Yuan, J.,
and Yankner, B. A.
(2000)
Nature
407,
802-808[CrossRef][Medline]
[Order article via Infotrieve]
|
| 57.
|
Ahmed, N.,
Nasman, P.,
and Wahlgren, N. G.
(2000)
Stroke
31,
1250-1255[Abstract/Free Full Text]
|
| 58.
|
Allen, G. S.,
and Banghart, S. B.
(1979)
Neurosurgery
4,
37-42[Medline]
[Order article via Infotrieve]
|
| 59.
|
Mohr, J. P.,
Orgogozo, J. M.,
Harrison, M. J. G.,
Hennerici, M.,
Wahlgren, N. G.,
Gelmers, J. H.,
Matínez-Vila, E.,
Dycka, J.,
and Tetternborn, D.
(1994)
Cerebrovasc. Dis.
4,
197-203
|
| 60.
|
Fogelholm, R.,
Erila, T.,
Palomaki, H.,
Murros, K.,
and Kaste, M.
(2001)
Cerebrovasc. Dis.
10,
189-193
|
| 61.
|
Horn, J.,
de Haan, R. J.,
Vermeulen, M.,
and Limburg, M.
(2001)
Stroke
32,
461-465[Abstract/Free Full Text]
|
| 62.
|
Hoffmesiter, F.,
Kazda, S.,
and Krause, H. P.
(1979)
Acta Neurol. Scand.
60,
358-359
|
| 63.
|
Roda, J. M.,
Carceller, F.,
Diez-Tejedor, E.,
and Avendaño, C.
(1995)
Stroke
26,
1888-1892[Abstract/Free Full Text]
|
| 64.
|
Maroto, R.,
de la Fuente, M. T.,
Artalejo, A. R.,
Abad, F.,
López, M. G.,
García-Sancho, J.,
and García, A. G.
(1994)
Eur. J. Pharmacol.
270,
331-339[CrossRef][Medline]
[Order article via Infotrieve]
|
| 65.
|
Maroto, R.,
de la Fuente, M. T.,
Zapater, P.,
Abad, F.,
Esquerro, E.,
and Garcia, A. G.
(1996)
Brain Res.
714,
209-214[CrossRef][Medline]
[Order article via Infotrieve]
|
| 66.
|
Murphy, T. H.,
Worley, P. F.,
and Baraban, J. M.
(1991)
Neuron
7,
625-635[CrossRef][Medline]
[Order article via Infotrieve]
|
| 67.
|
Blank, W. K.,
and Kirshner, H. S.
(1977)
Brain Res.
123,
113-124[CrossRef][Medline]
[Order article via Infotrieve]
|
Copyright © 2001 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
A. G. Garcia, A. M. Garcia-De-Diego, L. Gandia, R. Borges, and J. Garcia-Sancho
Calcium signaling and exocytosis in adrenal chromaffin cells.
Physiol Rev,
October 1, 2006;
86(4):
1093 - 1131.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
X. Chen, X. Zhang, H. Kubo, D. M. Harris, G. D. Mills, J. Moyer, R. Berretta, S. T. Potts, J. D. Marsh, and S. R. Houser
Ca2+ Influx-Induced Sarcoplasmic Reticulum Ca2+ Overload Causes Mitochondrial-Dependent Apoptosis in Ventricular Myocytes
Circ. Res.,
November 11, 2005;
97(10):
1009 - 1017.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Tanaka, M. Nangaku, T. Miyata, R. Inagi, T. Ohse, J. R. Ingelfinger, and T. Fujita
Blockade of Calcium Influx through L-Type Calcium Channels Attenuates Mitochondrial Injury and Apoptosis in Hypoxic Renal Tubular Cells
J. Am. Soc. Nephrol.,
September 1, 2004;
15(9):
2320 - 2333.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2001 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|